And a member of the G 2 Cancer Res 2008, 68:7905 7914. 17th Kitazaki T, Oka M, Nakamura Y, et al. Gefitinib, a tyrosine kinase inhibitor, directly AZD6244 606143-52-6 inhibits the function of P-glycoprotein in multidrug-resistant cancer cells. Lung cancer. 2005, 49:337 343. 18th Shi Z, Peng XX, Kim W, et al. Erlotinib subfamily antagonizes ATP-binding cassette B1 and member of the ATP binding cassette subfamily G member 2 resistance mediated by drug. Cancer Res 2007, 11020 67:11012. 19th Tao SY, Liang YJ, Wang F, et al. ABCB1 and ABCC1 Cediranib reverse multidrug resistance mediated by inhibition of its transport function. Cancer Chemother Pharmacol. 2009, 64:961 969. 20th LS Zheng, Wang F, Li YH, et al. Vandetanib antagonized ABCC1 and ABCG2 mediated multidrug resistance by inhibiting its transport function.
PLoS One. 2009, 4: e5172. 21st Dai CL, Liang YJ, Wang YS, et al. Sensitization of ABCG2-overexpressing cells to conventional chemotherapeutic agent by Canertinib HER2 inhibitor sunitinib was associated with inhibition of ABCG2 function. Cancer Lett. 2009, 279:74 83rd 22nd Fu L, Liang Y, Deng L, et al. Characterization of tetrandrine, a potent inhibitor . Cancer Chemother Pharmacol. 2004, 53:349 356. 23rd Robey RW, Medina Perez WY, Nishiyama K, et al. The overexpression of the ATP binding cassette transporter H Half, ABCG2, in flavopiridol-resistant human breast cancer cells. Clin Cancer Res. 2001, 7:145 152nd 24th Zhang JY, Wu HY, Xia, XK, et al. Anthraquinone derivative 1403P 3 induces apoptosis in KB cells by reactive oxygen species and KBv200 independent Ngig of mitochondrial and death receptor pathway.
Cancer Biol Ther. 2007, 1421 6:1413. 25th Robey RW, Honjo Y, Morisaki K, et al. Mutations at amino 482 in the ABCG2 gene urepositionen affect substrate and antagonist specificity of t. Br J Cancer. 2003, 1978 89:1971. 26th Chen LM, Wu XP, Ruan JW, et al. Screening novel, potent modulators of multidrug-resistant imidazole derivatives. Oncol Res 2004, 14:355 362. Mi et al. Cancer Res 10 Page. Author manuscript, increases available in PMC 15th October 2011. PA Author Manuscript NIH-PA Author Manuscript NIH Author Manuscript NIH-PA-27. Shi Z, Liang YJ, Chen ZS, et al. Reversal of MDR1 / P-glycoprotein-mediated multidrug resistance by vector-based RNA interference in vitro and in vivo. Cancer Biol Ther. 2006, 47th 05.39 clock 28th Chen LM, Liang YJ, Ruan JW, et al.
Reversal of P gp-mediated multidrug resistance in vitro and in vivo by FG020318. J. Pharm Pharmacol. 2004, 1066 56:1061. 29th Rabindran SK, Ross DD, Doyle LA, Yang W, Greenberger LM. Fumitremorgin C versa transfected multidrug resistance in cells with the resistance protein in breast cancer. Cancer Res 2000, 60:47 50th 30th Wed Y, Lou L. ZD6474 versa multidrug resistance by directly inhibiting the function of Pglycoprotein. Br J Cancer. 2007, 97:934 940. 31st Dive C, Workman P, Watson JV. Improved methods for intracellular Re enzyme inhibition kinetics and reaction by flow cytometry. Cytometry. 1987, 8:552 561st 32nd SJ Tseng, JP Hsu. A comparison of Parametersch Tzung procedures for the Michaelis-Menten model. J Biol Theor. 1990, 145:457 464th 33rd Bradford MM A rapid and sensitive method for the quantitation of microgram quantities of protein using the principle of protein-dye binding. Anal Biochem. 1976, 72:248 254. 34th Ambudkar SV. Drug stimulated ATPase in crude membranes of human MDR1 transfected